Name: 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference
Start: 2023-02-08
End: 2023-02-09
Location: Double Tree by Hilton, San Diego - Mission Valley

WHAT TO EXPECT

Effective Microbiome Therapeutics in Production
Role of human skin microbiome in precision health
The increasing pro bacterial beauty industry
Business collaborations- Regulations and Investments
Microbiome as a science and its clinical applications- skin, gut & women’s health
Regulatory pathways
Prebiotics, Probiotics and Postbiotics
R&D to commercialization- effectively translating research into commercialization
Rightly educating the consumer

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

Microbiome discovery
Department of Biochemistry and Immunology
Microbiome science
Microbiology
Biological Science
Gut Biology
Human microbiome
Drug discovery
Therapeutics
Immunotherapy

Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of:

Microbiology
Microbiome therapeutics
Microbiome
Gastroenterology
Immunology
Bioinformatics
Obstetrics
Neonatology
Functional foods
Pediatrics
Nutritionists/dieticians
Gut inflammation
Mucosal immunity
Immunopharmacology Group
Gut disgiosis
Skin conditions
Baterria and excema gut and bacteria
Infant and gut
Pediatric and git
Gut brain axis

CONFERENCE AGENDA

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson Robert H. Schiestl, Professor emeritus of Pathology and Environmental Health Sciences and Radiation Oncology, UCLA Schools of Medicine and Public Health	08:55 - 09:00
APPLYING NEW MICROBIOME FINDING & REGULATORY UPDATES
Keynote Presentation: Diet and the Microbiome-Gut-Brain Axis: The Role in Health and Disease Leigh A. Frame, Director, George Washington School of Medicine & Health Sciences	09:00 - 09:30
Non-invasive Functional Assessment of the Microbiome from Exhaled Breath Ace Hatch, Senior Biomarker Scientist, Owlstone Medical	09:30 - 10:00
Deployment of Metaproteomics Approaches for Characterizing Human Gut Microbiomes for Contrasting Healthy vs. Dysbiotic Conditions Robert L Hettich, Distinguished Research Staff Member, Oak Ridge National Laboratory	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Recently Improved Method to Use 16S (bacterial) and ITS (Fungal) Genes to Cheaply and Rapidly Identify Species (Not just Genus)-Level Microbiome Populations Seth D. Crosby, Director, Research Collaborations, Washington University School of Medicine	11:15 - 11:45
Lactobacillus Johnsonii 456 a Novel Probiotic Prevents and treats Inflammation Caused Diseases, Cancer, Cardiovascular diseases, Diabetes and Obesity. Robert H. Schiestl, Professor emeritus of Pathology and Environmental Health Sciences and Radiation Oncology, UCLA Schools of Medicine and Public Health	11:45 - 12:40
How we are affecting the health of probiotics Dana Buckman, CEO, BioForm Solutions	12:40 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
ANALYZING THE CONCEPT OF PROBIOTICS FOR HEALTHY GUT
An IP strategy for Microbiome Innovators is not a list of patents rights. Craig Thomson, Partner, HGF IP Limited	14:15 - 14:45
Applied Microbiomics Julius Goepp, CEO, Evimero	14:45 - 15:15
Combining genomics and proteomics for linking identity and function Jan Struckmann Poulsen, PhD student \| Department of Chemistry and Bioscience, Aalborg University	15:15 - 15:45
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:45 - 16:30
Back to Health - An Evolutionary Biology Perspective on the Skin Microbiome Juliana Durack, VP of Research and Product Development, Symbiome	16:30 - 17:00
Modulation of the Aging Gut Microbiome to Improve Health Andrea Azcarate-Peril, Associate Professor of Medicine, Director, UNC Microbiome Core, School of Medicine, University of North Carolina at Chapel Hill	17:00 - 17:30
Drinks Reception & Networking End of Day 1	17:30 - 17:30
Closing Remarks from the Chairperson	17:30 - 17:30

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets	08:50 - 08:55
Opening Remarks from the Chairperson Robert H. Schiestl, Professor emeritus of Pathology and Environmental Health Sciences and Radiation Oncology, UCLA Schools of Medicine and Public Health	08:55 - 09:00
EFFECTIVELY TRANSLATING MICROBIOME RESEARCH INTO PRODUCTS
Fiber as a Prebiotic Katrine L. Whiteson, Associate Professor, Molecular Biology and Biochemistry School of Biological Sciences,, University of California Irvine	09:00 - 09:30
Effective Microbiome Therapeutics in Production Suparna Mitra, University Academic fellow (Bioinformatics lead), University of Leeds	09:30 - 10:00
Microbiome discovery in gut and beyond gut, and GMO probiotics for health Ravichandra Vemuri, Microbiome Scientist at Department of Pathology, Wake Forest School of Medicine, NC.	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Next-generation probiotics against enteric pathogen infection and chronic inflammatory disease Arun K. Bhunia, Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease	11:15 - 11:45
ANALYZING THE CONCEPT OF PROBIOTICS
Precise Microbiome Editing to Change How We Treat Chronic Bacterial Diseases Yug Varma, CEO, Phi Therapeutics	11:45 - 12:15
Oral-Systemic Microbiome Connection and its Modulation Emily Stein, CEO, Primal Health Inc.	12:15 - 12:45
Standards for Microbiome Measurements Scott A. Jackson, Leader – Complex Microbial Systems Group, NIST - National Institute of Standards and Technology	12:45 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
Breakout Session by Robert L Hettich, Distinguished Research Staff Member, Oak Ridge National Laboratory	14:15 - 14:45
Closing Remarks from the Chairman Robert H. Schiestl, Professor emeritus of Pathology and Environmental Health Sciences and Radiation Oncology, UCLA Schools of Medicine and Public Health	14:45 - 14:45
End of Conference	14:45 - 14:45

CONFERENCE SPEAKERS

ADVISORS

Seth D. Crosby

Director, Research Collaborations, Washington University School of Medicine

Julius Goepp

CEO, Evimero

Arun K. Bhunia

Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease

Peter Leighton

CEO, ProSperity Bioscience

Maya Ivanjesku

Chief Scientific Officer, Dakota Biotech

SPEAKERS

Seth D. Crosby

Director, Research Collaborations, Washington University School of Medicine

Juliana Durack

VP of Research and Product Development, Symbiome

Craig Thomson

Partner, HGF IP Limited

Arun K. Bhunia

Professor of Food Microbiology, Chair, Interdepartmental Food Science Graduate Program, Department of Food Science, Purdue Institute of Inflammation, Immunology and Infectious Disease